SCHEMBL4918252

SCHEMBL4918252

CC(C)(C)c1cc(C=CC(=O)c2ccc3ccccc3c2)cc(C(C)(C)C)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1B1 Q16678 3/20 0.67
ABCG2 Q9UNQ0 4/20 0.61
ABCB1 P08183 1/20 0.61
CYP1A1 P04798 2/20 0.60
CYP1A2 P05177 2/20 0.60
CYP3A4 P08684 3/20 0.57
TP53 P04637 1/20 0.57
MAPT P10636 1/20 0.57
ALOX15 P16050 1/20 0.57
MAPK1 P28482 1/20 0.57
BLM P54132 1/20 0.57
CASP7 P55210 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
HSD17B10 Q99714 1/20 0.57
TDP1 Q9NUW8 1/20 0.57
CYP2D6 P10635 1/20 0.56
PTPN1 P18031 1/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
POLB P06746 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formaldehyde SCHEMBL4921857 0.97 CYP1B1 (0.63) CYP1B1ABCG2ABCB1CYP1A1CYP1A2
SCHEMBL4910956 0.86 CYP1B1 (0.67) CYP1B1ABCG2ABCB1CYP1A1CYP1A2
SCHEMBL658562 0.81 CYP1B1 (1.00) CYP1B1ABCG2ABCB1CYP1A1CYP1A2
SCHEMBL29639743 0.81 CYP1B1 (1.00) CYP1B1ABCG2ABCB1CYP1A1CYP1A2
SCHEMBL658561 0.81 CYP1B1 (1.00) CYP1B1ABCG2ABCB1CYP1A1CYP1A2
SCHEMBL29805401 0.81 CYP1B1 (1.00) CYP1B1ABCG2ABCB1CYP1A1CYP1A2
SCHEMBL656428 0.81 CYP1B1 (0.81) CYP1B1ABCG2ABCB1CYP1A1CYP1A2
SCHEMBL656427 0.81 CYP1B1 (0.81) CYP1B1ABCG2ABCB1CYP1A1CYP1A2
SCHEMBL14918992 0.80 MAPT (0.81) CYP1B1CYP1A1CYP3A4TP53MAPT
SCHEMBL14918994 0.80 MAPT (0.81) CYP1B1CYP1A1CYP3A4TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9023490-B2 Extended pi-conjugated platinum (II) complexes VERSITECH LIMITED (CN) 2015-05-05 US disclosed
US-20080309227-A1 EXTENDED PI-CONJUGATED PLATINUM (II) COMPLEXES VERSITECH LIMITED (CN) 2008-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080309227-A1 EXTENDED PI-CONJUGATED PLATINUM (II) COMPLEXES LIG4, PARG, PARN CYP1B1 4546/4885ABCG2 4064/4885ABCB1 3716/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.